Nearly half the world's population experiences menopause, yet many of its emotional, cognitive and social impacts may never be discussed during medical appointments. New research out today in JAMA Network Open led by UMD Professor Yulin Hswen highlights these “silent symptoms” by comparing clinical notes that include menopause symptoms with the top Reddit posts in menopause forums.

Using AI-driven materials design, a team of researchers at University of Toronto Engineering has discovered a new set of metal alloys that retain their strength under extreme conditions. The materials are well suited to additive manufacturing, also known as 3D metal printing, and could lead to enhanced, custom-made parts for aerospace, power generation and more.

Solar energy is becoming one of the world’s most important sources of electricity. In Lithuania, the number of solar power plants is also growing rapidly, and the energy they produce is playing an ever more significant role in the country’s energy system. At the same time, however, one of the key challenges is becoming more pronounced: solar power generation remains highly dependent on weather conditions.

Nearly nine in 10 pregnant participants in a study led by biomedical engineers at UBC did not achieve recommended seatbelt placement, even after instruction and hands-on guidance. Among 333 participants, only 11.4 per cent were able to place the seatbelt as recommended, suggesting current seatbelt guidance may be difficult for many pregnant people to achieve in practice.

Researchers at King Abdullah University of Science and Technology (KAUST) have developed a lightweight wearable microneedle patch capable of continuously monitoring drug concentrations beneath the skin and wirelessly transmitting the data to a smartphone in real time. Published in Device, the study demonstrates how wearable technologies could move beyond tracking physical activity and vital signs to monitoring therapies inside the body. Tested using the antibiotic vancomycin, the platform successfully tracked changing drug levels in laboratory and preclinical studies, highlighting the potential for future personalized drug management.